ArticleArchives of rehabilitation research and clinical translation2025
Understanding Cannabis Use After Spinal Cord Injury: A Canadian Survey Study.
Article in Archives of rehabilitation research and clinical translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe the prevalence and characteristics of cannabis use among Canadians with spinal cord injury (SCI). Design: Observational study. Setting: Online survey. Participants: Canadian adults with any level or severity of SCI (N=80). In total, 136 individuals were screened for participation, of which 80 (61.2% men; mean age: 57.7y) completed the survey. Interventions: Not applicable. Main Outcome Measures: Prevalence and frequency of cannabis use; reasons for and against use; perceived effectiveness; adverse events; and modality of cannabis consumption. Results: Overall, 42.5% of participants reported cannabis use postinjury, and 37.5% were current users, exceeding the general Canadian population's usage rate (25%). Postinjury, the primary reasons for cannabis use shifted from recreation (25%) to alleviating pain (36.3%) and improving sleep (30%), with users perceiving moderate effectiveness. Reported adverse events were generally mild and infrequent, with fatigue being the most common (11.3%). Edibles replaced smoking as the most common modality of cannabis consumption postinjury. No significant associations were found between cannabis use and demographic variables, including sex, education, or employment status. Conclusions: This small survey highlights the prevalence and therapeutic motivations for cannabis use among Canadians with SCI, with a shift toward medicinal applications postinjury. With moderate perceived effectiveness and a low prevalence of only mild side effects, future research is warranted to evaluate cannabis' efficacy and safety in this population and to address barriers to its use, including stigma and health concerns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.